Vilin Bio Med, a company in the Pharmaceuticals industry, reported revenue of ₹33 crore and net profit of ₹1.78 crore for the March 2026 quarter.
Vilin Bio Med (NSE: VILINBIO-SM) closed at ₹52.75 on 20 Nov 2026. Its market capitalisation is ₹80 crore and it trades at 41.7 times earnings.
Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.